REG - Eco Animal Health Gp - EBT Share Purchase

ECO Animal HealthAnnouncement

22/10/2024 11:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241022:nRSV1469Ja&default-theme=true

RNS Number : 1469J  Eco Animal Health Group PLC  22 October 2024

22 October 2024

 

 

 

ECO Animal Health Group plc

("ECO" or the "Company")

 

EBT Share Purchase

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health
company with a portfolio of marketed veterinary products and a maturing
proprietary R&D pipeline, announces it has been notified that on 21
October 2024 the trustees of the ECO Animal Health Group EBT (the "EBT")
purchased a further 32,072 ordinary shares of 5 pence each in the Company
("Ordinary Shares") at a price of 74.63 pence per Ordinary Share.

These Ordinary Shares are to be held in the EBT and are intended to be used to
satisfy the future vesting of share options granted to employees of the
Company. The EBT is a discretionary trust for the benefit of the Company's
employees, including the Directors of the Company. The purchase of Ordinary
Shares by the EBT has been funded by a gift provided by the Company from its
existing cash resources.

Following this transaction, a total of 270,000 Ordinary Shares are held by the
EBT, representing approximately 0.40 per cent. of the Company's total voting
rights.

-Ends-

For further information please contact:

 

 ECO Animal Health Group plc                                    020 8447 8899

 David Hallas (CEO)

 Christopher Wilks (CFO)
 Singer Capital Markets (Nominated Adviser & Joint Broker)      020 7496 3000

 Phil Davies

 Sam Butcher
 Investec (Joint Broker)                                        020 7597 5970

 Gary Clarence

 Lydia Zychowska
 Equity Development                                             020 7065 2692

 Hannah Crowe

 Matt Evans
 ICR Consilium (Financial PR)                                   020 3709 5700

 Mary-Jane Elliott                                              ecoanimalhealth@consilium-comms.com

 Jessica Hodgson

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing
branded veterinary pharmaceuticals globally, with expertise in antibiotics and
vaccines for pigs and poultry. We have a maturing proprietary R&D
pipeline.

 Headquartered in the UK, with global offices including R&D and
manufacturing, we have marketing authorisations in over 70 countries and
employ over 200 people worldwide.

 Our lead product, Aivlosin® is a proprietary, patented medication which is
effective against both respiratory and intestinal diseases in pigs and
poultry.

Click here for more information: https://ecoanimalhealth.com
(https://ecoanimalhealth.com/)

( )

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPGGAUUPCUBP